News

Nitinotes Begins Pivotal Clinical Trial for Revolutionary Surgical System

Nitinotes Begins Pivotal Clinical Trial for Revolutionary Surgical System

Significant Advancement in Surgical Solutions

Nitinotes Ltd., an innovative medical technology company, has achieved a major milestone by initiating its EASE™ Clinical Trial. The trial aims to evaluate the effectiveness of the EndoZip™ Automated Suturing System, a game-changing technology designed for endoscopic sleeve gastroplasty (ESG). This pivotal trial marks a crucial step towards regulatory submission in the U.S., highlighting Nitinotes' commitment to improving obesity treatments.

Understanding the EASE™ Clinical Trial

The EASE™ Clinical Trial is a multicenter, randomized, two-arm, and blinded study. It will compare the safety and effectiveness of the automated ESG procedure utilizing the EndoZip™ system against the traditional manual suturing method known as Apollo OverStitch®. The trial is designed to enroll approximately 184 patients across 10 clinical sites in the U.S. and Europe. With a comprehensive 12-month follow-up, the study aims to generate robust clinical evidence that will support the potential regulatory approval of this innovative technology.

Why the EASE™ Trial Matters

The increasing prevalence of obesity, which impacts over 650 million adults globally, necessitates effective and sustainable treatment methods. Many individuals struggle to maintain weight loss through traditional lifestyle modifications or medications alone. ESG is emerging as a promising minimally invasive option, and the demand for advanced technologies that enhance usability and consistency in procedural delivery is rapidly growing.

The EASE™ trial is especially significant as it is the first randomized study focusing on an automated ESG approach, representing a potential leap forward in minimally invasive bariatric care. Dr. Steven Shamah, a prominent U.S. investigator for the trial, expressed that it is crucial for closing the treatment gap between less effective therapies and invasive bariatric surgeries.

Clinical Objectives and Expected Outcomes

Beyond assessing clinical endpoints, the trial will also evaluate physician-reported outcomes regarding their experience with the procedure. Key factors will include ease of use and workflow efficiency, helping to further refine the automated suturing process. This initiative aligns with FDA guidelines intended to support future U.S. regulatory submissions.

Momentum with CE Mark Approval

The initiation of patient treatment within the EASE™ Clinical Trial is backed by Nitinotes’ recent achievement of CE Mark approval for the EndoZip™ system. This approval enables a commercial launch in the European Union and other regions, propelling the company’s mission to enhance obesity treatment options.

Lloyd Diamond, CEO of Nitinotes, emphasized the importance of advancing automation in treating obesity. He praised the efforts of Dr. Shamah and the Lenox Hill | Northwell Health team, acknowledging their vital role in kickstarting this trial in the U.S. and preparing other clinical sites for enrollment.

A Future of Automated Solutions in Obesity Treatment

As the trial progresses, additional clinical sites are expected to initiate patient enrollment, amplifying the reach and impact of this important study. The results from the EASE™ Clinical Trial may pave the way for wider acceptance and implementation of automated ESG techniques, ultimately transforming the landscape of obesity management.

About Nitinotes

Nitinotes is a pioneering medical device company focused on automated endoluminal suturing solutions for treating obesity. The flagship product, EndoZip™, is a fully automated platform that aims to standardize endoluminal suturing. Currently investigational in the U.S., EndoZip™ has received CE Mark approval, allowing it to enter the European market.

Frequently Asked Questions

What is the EASE™ Clinical Trial?

The EASE™ Clinical Trial is a pivotal study evaluating the safety and effectiveness of the automated EndoZip™ suturing system compared to manual techniques in endoscopic sleeve gastroplasty.

Why is obesity treatment important?

Obesity affects millions globally and leads to various health complications. Effective treatment options are vital for improving health and quality of life.

What does CE Mark approval mean for EndoZip™?

CE Mark approval allows Nitinotes to commercially launch the EndoZip™ system in the European Union and other markets that recognize it.

Who is involved in the EASE™ Clinical Trial?

The trial involves multiple clinical sites and physicians, including Dr. Steven Shamah, who is leading the U.S. investigation for the procedure.

What are the potential benefits of the EndoZip™ system?

The EndoZip™ system aims to enhance the efficiency, safety, and outcomes of the ESG procedure compared to traditional methods.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ontario Airport Braces for Holiday Travel Surge

Updated Category News Views 92

Gearing Up for a Thanksgiving Travel Boom Think Thanksgiving brings only turkey to the table? Down in Ontario, California, it's all about jet fuel and passenger counts. The Ontario International Airport (ONT) is where the skies are buzzing, forecasting over 227,000 passengers trying to soak up the holiday vibes by air. Compare that to the numbers when the local folks...

Continue Reading
LinkedIn Shines: Brands Face Social Media Slump

Updated Category News Views 71

LinkedIn: The Unsung Hero in Social Platforms In a world where social media seems to be as unpredictable as the stock market, LinkedIn is surprisingly holding the line. According to Vista Social's 2027 report, LinkedIn proudly boasts the highest median engagement rate among brand pages at 5.8%. Now, in the wild west of social media, where reach is getting tougher to snag,...

Continue Reading
First Time Homebuyer Tips for Southern Maryland Success

Updated Category News Views 54

Shaking Up First-Time Homebuyer Assumptions Ever hear that age-old nonsense about needing a fat stack of cash as a down payment before you can snag your first home? Yeah, turns out that's about as outdated as a rotary phone. Robin Cavallaro from RE/MAX Realty Group in Annapolis is setting the record straight for first-time buyers in Southern Maryland. Down Payment Myths...

Continue Reading
HLTH USA 2026 Spotlights AI and Health Innovation

Updated Category News Views 77

The Pulse of Innovation at HLTH USA 2026 Diving headfirst into the heart of healthcare innovation, HLTH USA 2026 kicked off with gusto in Las Vegas. Discussions are swirling around AI advancements and the next generation of payer-provider collaboration. Who knew healthcare could be this thrilling? The event is already shaping up to be a powerhouse of change, buzzing with...

Continue Reading
Bacterial Breakthrough in Cancer Therapy: Game Changer?

Updated Category News Views 60

Blurring Lines Between Bugs and Biotech Well, wouldn't you know it, the eggheads over at Jeonbuk National University in South Korea are at it again, pushing the boundaries of what these little bacterial buggers can do. This time, they’ve had a crack at cancer therapy, using engineered Salmonella to pack a double punch against breast cancer in mice. Now, if that ain't...

Continue Reading
Tigo Energy Faces Lawsuit: Key Details for Investors

Updated Category News Views 89

Tigo Energy Inc.'s Troubles: A Stock Drop and Legal Woes You see, not every day do you wake up to find your investment taking a nose dive by 36.76%. But that’s exactly what happened to Tigo Energy, Inc. (NASDAQ: TYGO) after some shaky announcements. A Rollercoaster for Investors On August 4, 2026, Tigo hit investors with a one-two punch: revised financial outlook and...

Continue Reading
Rock Tech Uncovers Major Lithium Discovery at Victory

Updated Category News Views 84

Rock Tech's Game-Changer at Victory Folks, we've got a shake-up in the lithium landscape over in Ontario, courtesy of Rock Tech Lithium Inc. They just unearthed something quite promising at their Victory Project: a spanking new spodumene-bearing pegmatite discovery. Now I know, if you're like me, you're thinking, 'What's the angle here?' Well, this isn't just another hole...

Continue Reading
Pine Tree Bets Big on Tulsa Hills Shopping Center

Updated Category News Views 152

Pine Tree's Latest Move in Retail Real Estate Ya ever watch a company make a move so aligned with its playbook that it feels like a script straight outta the boardroom? That's Pine Tree with its recent snag of Tulsa Hills Shopping Center for a cool $108 million. This ain't just any retail spot; it's a bustling hub nestled within the posh outskirts of Jenks, Oklahoma....

Continue Reading
Kansai Powers Up US Grid with Bold Investment Move

Updated Category News Views 99

Betting Big on Battery Storage Let's unpack this big move by Kansai Electric. Anytime a major player like Kansai steps out of its home turf, folks better pay attention. Looks like Kansai's gotten cozy with Elevate and ArcLight, nabbing a minority stake in Prospect Power. This ain't your average widget factory—it's a beefy 150MW/600MWh battery energy storage facility in...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 109

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading

Top 5 Most Recently Viewed Articles

Algeness® VL Filler Receives Marketing Approval in China

Updated Category News Views 273

Exciting Developments for Advanced Aesthetic Technologies Advanced Aesthetic Technologies, Inc. (AAT) recently celebrated a significant milestone with the approval of their Algeness® VL agarose facial injection filler for marketing in China. This landmark achievement opens up new avenues for AAT in expanding their product offerings in the Asian market and showcases their...

Continue Reading
Criminal Charges Anticipated in Trump Campaign Hacking Case

Updated Category News Views 154

Criminal Charges Expected in Trump Campaign Hacking Case U.S. authorities are preparing to file criminal charges regarding an incident in which the Trump campaign claimed its internal communications were hacked, allegedly by the Iranian government. This concerning situation has drawn the attention of both the public and officials, raising serious issues surrounding...

Continue Reading
Semler Scientific Faces Class Action Lawsuit: What Investors Need to Know

Updated Category News Views 187

Semler Scientific and the Class Action Lawsuit Overview In recent news, a class action lawsuit has taken center stage involving Semler Scientific, Inc. (SMLR). Investors who have experienced losses related to their investments in Semler are advised to take note of this development, which may directly impact their financial outcomes. Understanding the Lawsuit This class...

Continue Reading
FTC Solar Engages Investors at Key Industry Conferences

Updated Category News Views 159

FTC Solar Engages Investors at Key Industry Conferences FTC Solar, Inc. (Nasdaq: FTCI), an innovative leader in solar tracker systems and engineering services, is set to make significant strides in connecting with investors at three prominent conferences. These events provide a platform for the management team, including CEO Yann Brandt, to engage in discussions that...

Continue Reading
Anixa Biosciences Set to Share Innovations in Cancer Therapy

Updated Category News Views 88

Anixa Biosciences Set to Conduct a Notable Presentation Anixa Biosciences, Inc. (NASDAQ: ANIX), a leading biotechnology firm dedicated to the treatment and prevention of cancer, has taken a significant step forward by announcing its participation in a prestigious investment conference. This event, the H.C. Wainwright 27th Annual Global Investment Conference, promises to...

Continue Reading